C
Cradle Genomics
Providing knowledge that helps every pregnancy
About Cradle Genomics
Cradle Genomics is a pioneering company headquartered in San Diego, specializing in non-invasive prenatal testing (NIPT). The company focuses on providing the most comprehensive fetal genetic analysis and pregnancy health screening solutions during the earliest stages of pregnancy. Cradle Genomics serves expectant parents and healthcare providers, aiming to improve patient care and enable global access to advanced prenatal solutions. The business operates in the healthcare and biotechnology market, leveraging cutting-edge genetic analysis of fetal cells collected in the first trimester without posing any risk to the mother or fetus. Cradle Genomics generates revenue through the sale of its prenatal testing services, targeting a broad market of healthcare institutions and individual clients seeking early and accurate prenatal information.
Source: Dealroom company dataAt a glance
- Founded
- 2018
- Headquarters
- San Diego, United States
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Illumina Ventures
Section 32
Pacific West Bank
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Cradle Genomics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cradle Genomics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.